nodules were in the periphery of the lung and amenable to EMN-TTNA as determined a priori by a radiology core laboratory utilizing planning software. Mean nodule size is 1.78 cm with nodules located 2.2 cm from the pleura. There have been no bleeding complications to date. 10 patients (18%) who underwent EMN-TTNA had a pneumothorax of which only 5 (9%) required drainage.
Conclusion: This is the first study designed to evaluate the diagnostic yield of a staged procedure using EBUS, ENB and EMN-TTNA for the diagnosis of pulmonary nodules. If effective, the staged procedure will increase minimally invasive procedural diagnostic yield for pulmonary nodules. Background and Aims: Despite the improvement of diagnostic ability of bronchoscopy with advanced techniques for peripheral pulmonary lesions (PPLs), it has still been insufficient compared to transthoracic needle aspiration/biopsy. We focused on cryobiopsy that enables us to obtain tissues with large quantity and high quality; nowadays, it has become the first option for the diagnosis of interstitial lung diseases. Thus, we applied cryobiopsy for PPLs, and investigated the utility.
Methods: Consecutive patients who underwent diagnostic bronchoscopy with cryobiopsy for PPLs at our hospital from June to November 2017 were collected. The cases with the purpose of rebiopsy were excluded. All procedures were performed with the same setting: using radial endobronchial ultrasound (R-EBUS), virtual bronchoscopy, and Xray fluoroscopy under local anaesthesia. After usual sampling (forceps, brush, or aspiration needle), cryobiopsy was performed where the same location was estimated by X-ray fluoroscopy. The diagnostic value and the safety of cryobiopsy were reviewed.
Results: We performed cryobiopsy for 116 cases with PPLs in this period. The median (range) size was 22.7 (7.1-115.4) mm, and the features (solid, part-solid, nonsolid) were 68.1%, 25.9%, 6.0%, respectively. Besides, the PPLs mainly located at peripheral 1/3 (69.8%), and 21.6% showed negative bronchus sign. The diagnostic yield was 91.4%, and 10 cases were diagnosable only by cryobiopsy (the additional effect was 8.6%). This advantage was different among each R-EBUS findings (within, adjacent to, invisible); the diagnostic yield improved from 95.4%, 71.4%, 50.0% to 96.9%, 85.7%, 50.0%, respectively. On the other hand, 1 case (0.9%) caused mild pneumothorax, and 39 cases (33.6%) caused moderate to severe bleeding. However, no case needed any intervention or admission.
Conclusion: Cryobiopsy has a great potential to break through the diagnostic bronchoscopy for PPLs. Background and Aims: Transbronchial cryobiopsy (TBCB) is a novel way to obtain large lung biopsies without crash artefact. However, correlation of freezing time with cryobiopsy size and complications has not been evaluated in vivo. The aim of this study is to reveal the correlation between cryobiopsy freezing time and size of cryobiopsy specimens, and evaluate incidence of complications and histological quality of the cryobiopsy specimens in different freezing times.
Methods: Individual cryobiopsies were obtained from patients who had suspected ILD based on clinical information, laboratory tests and HRCT with atypical findings requiring lung biopsy. The freezing time was increased incrementally from 3 to 6s to achieve individual cryobiopsies.
Results: 33 patients were enrolled and 142 transbronchial cryobiopsies were taken in this study. The mean size of the cryobiopsy ranged from 9.2 AE 0.82 to 18.83 AE 1.27 mm 2 . A significant positive correlation between increased freezing times and cryobiopsy sizes was observed in this study, but no statistical difference in diagnostic yield was observed between each group. A significant higher proportion (22.86%) of specimen swelling was observed when the freezing time exceeded 5s. Haemorrhage occurred in 103(72.54%) individual cryobiopsies and 4(12.12%) cases of pneumothorax were found by X-ray. As the freezing time prolongs, the risk of severe bleeding significantly increases and reaches the highest level at 5s.
Conclusion:
The optimal freezing time begins with 3 or 4s, which is easily achievable and provides an adequate biopsy size whilst creating a safety threshold from complications. Background and Aims: The flexible cryoprobe is primarily used for cryoextraction of malignant airway stenosis and was introduced as an alternative method for mechanical tumour debunking, which is immediately effective. Because of extraordinarily well-preserved tissue samples from cryorecanalization procedures, the technique has been transferred to the biopsy of endobronchial or peripheral lesions. The aim of this study was to assess the diagnostic yield and to show the feasibility and safety of cryobiopsy using the flexible bronchoscope and semi-rigid pleuroscope.
Methods: In a single-centre, observational, retrospective study, patients underwent cryobiopsy using the flexible bronchoscope and semirigid pleuroscope were evaluated between January 2015 to May 2018.
